Skip to main content

Graft-versus-Host-Disease

Sitagliptin, a DPP-4 Inhibitor, Reduces the Incidence of Acute GVHD After Stem-Cell Transplant
Read More
Meeting Highlights
Ruxolitinib in Graft-versus-Host Disease: Practice-Changing Results
Read More
Outcomes for Patients Receiving Ibrutinib with or without Antifungal Therapy
Kori Daniels, PharmD, BCOP; Arpita Gandhi, PharmD, BCOP; Locke Bryan, MD; Amber Clemmons, PharmD, BCOP
Read More
The Safety Profile of Mini-Dose Methotrexate for Graft-versus-Host Disease Prophylaxis: Is There a Place for Folinic Acid Rescue?
Loriel J. Solodokin, PharmD, BCOP; Amir Steinberg, MD, FACP; Erin Moshier, MS
Read More
Horsies and Bunnies: Comparing Antithymocyte Globulin Drugs in Patients Undergoing Allogeneic Stem-Cell Transplant
Crystal Lu, PharmD, BCOP; Nancy Mikulandric, PharmD, BCOP; Meredith Grycki, PharmD, BCOP, BCPS; Vishnuprabha Vogel, PharmD, BCOP, BCPS; Shatha Farhan, MD; Edward Peres, MD; Nalini Janakiraman, MD; Klodiana Neme, PharmD, BCOP
Read More
Inadequate Transdermal Patch Absorption in a Patient with Scleroderma Associated with Graft-versus-Host Disease
Robert Mancini, PharmD, BCOP; Mallori Hooker, NP-C, AOCNP, BMTCN; William Kreisle, MD
Read More

Results 1 - 6 of 6